Nicolas Meneveau
Nicolas Meneveau is an expert in Cardiology at Centre Hospitalier Universitaire de Besançon (France). As of October 2026, ScienceLeadR ranks Nicolas Meneveau in the top 1% of experts worldwide for Pulmonary Embolism, Embolism and Thrombosis and Myocardial Ischemia. Nicolas Meneveau has authored 414 publications, the most recent in 2026, and is an investigator in 47 clinical trials, 11 of them ongoing. SLR score: 2,110 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Hematology - Public Health - Surgery
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1993 - 2026
Number : 414
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Prevalence, Predictors, and Clinical Implications of Residual Shunt After Patent Foramen Ovale Percutaneous Closure. PMID 42862913 — foramen ovale, patent, prevalence, blood circulation, foramen ovale | Circulation Top journal | 2026 | 0 |
| Standardised versus visual assessment of device success after percutaneous coronary intervention. PMID 42837202 — stents, percutaneous coronary intervention, angiography, algorithms, cardiac surgical procedures, wounds and injuries | EuroIntervention | 2026 | 1 |
| Intravascular lithotripsy in comparison to rotational atherectomy for calcified lesions: the ICARE OFDI randomised trial. PMID 42200665 — stents, atherectomy, wounds and injuries, lithotripsy | EuroIntervention | 2026 | 1 |
| Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism. PMID 41910345 — embolism, hemorrhage, fibrinolysis, pulmonary embolism, therapeutics, random allocation, catheters | N Engl J Med Top journal | 2026 | 2 |
| Missed Opportunity for Fibrinolysis in ST-Segment-Elevation Myocardial Infarction: The Nationwide France-PCI Registry. PMID 41821214 — registries, myocardial infarction, fibrinolysis, cardiovascular diseases, percutaneous coronary intervention, st elevation myocardial infarction, clinical medicine, reperfusion, electrocardiography | Eur Heart J Qual Care Clin Outcomes | 2026 | 0 |
Clinical Studies 47
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 2
Ongoing Clinical Trials
11 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| EASi PROTKT A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes high blood pressure and cardiovascular disease 2025-521188-11-00 — diabetes mellitus, hypertension, safety, blood, cardiovascular diseases, blood pressure, diabetes mellitus, type 2 | Phase 3 | Recruiting | 2025 |
| Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME CV) 2024-516652-18-00 — cardiovascular diseases, obesity, therapeutics, overweight | Phase 3 | Recruiting | 2025 |
| Personalized CT guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in non atrial fibrillation patients after transcatheter aortic valve implantation a pragmatic international multicentre randomized clinical trial (POPular ATLANTIS trial) 2023-504637-42-01 — constriction, pathologic, aortic valve stenosis, hemorrhage, atrial fibrillation, aortic valve, transcatheter aortic valve replacement, therapeutics | Phase 4 | Recruiting | 2023 |
| Safety and efficacy of very short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy in older patients undergoing percutaneous coronary intervention 2023-507545-28-00 — stents, safety, drug-eluting stents, pharmaceutical preparations, percutaneous coronary intervention, aged, therapeutics | Phase 4 | Recruiting | 2026 |
| The PERSEVERE Study NCT06588634 — thromboembolism, embolism, pulmonary embolism, therapeutics, thrombectomy, catheters | N/A | Recruiting | 2024 |
LeadR Networks
Main global connection map